高级检索
当前位置: 首页 > 详情页

Quality of therapeutic drug monitoring guidelines is suboptimal: an evaluation using the Appraisal of Guidelines for Research and Evaluation II instrument

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

单位: [1]Department of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu, China [2]Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu, China [3]Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education (Sichuan University), Chengdu, China [4]West China School of Pharmacy, Sichuan University, Chengdu, China [5]Pharmaceutical Department, China-Japan Friendship Hospital, Beijing, China [6]Chinese Cochrane Center, West China Hospital, Sichuan University, Chengdu, China [7]Department of Standardization, National Center for Medical Service Administration, National Health Commission of the People’s Republic of China, Beijing, China [8]Department of Pharmacy, Peking University Third Hospital, Beijing, China [9]Department of Pharmacy, The First Affiliated Hospital of Soochow University, Suzhou, China
出处:
ISSN:

关键词: Therapeutic drug monitoring (TDM) Guidelines Appraisal of guideline for research and evaluation (AGREE) II Quality assessment

摘要:
Objectives: Although therapeutic drug monitoring (TDM) guidelines are available, systematic evaluations of their methodological quality are scarce. This study aimed to assess the quality of current TDM guidelines using the Appraisal of Guidelines for Research and Evaluation (AGREE) II instrument. Study Design and Setting: We performed a systematic search to identify the relevant TDM guidelines in PubMed, EMBASE, CNKI, Wan Fang Database, CBM, VIP, four main guideline databases (NICE, NGC, GIN, and WHO guideline databases), and official websites of the governments and societies associated with TDM from the inception date to May 2018. Four independent appraisers rated the quality of each TDM guideline using the AGREE II instrument, and the mean score of each AGREE II item was calculated. The overall agreement among the appraisers was evaluated using the intraclass correlation coefficient (ICC). Results: Twenty-eight TDM guidelines satisfied the eligibility criteria from among 12,235 references. The overall agreement among the appraisers was substantial (0.700-0.880). The mean scores for the six AGREE II domains were scope and purpose, 67.7% (95% CI, 64.0-71.4%); stakeholder involvement, 39.8% (95% CI, 33.3-46.3%); rigor of development, 36.0% (95% CI, 28.1-43.9%); clarity and presentation, 61.6% (95% CI, 55.7-67.4%); applicability, 30.6% (95% CI, 26.4-34.8%); and editorial independence, 49.2% (95% CI, 40.0-58.6%). The reviewers recommended only four guidelines, and most of the TDM guidelines were rated as "recommended with modifications." Conclusion: Overall, the quality of TDM guidelines is suboptimal according to the evaluation using the AGREE II instrument. The domains of applicability, rigor of development, stakeholder involvement, and editorial independence of the guidelines need to be reported. In addition, guideline developers closely adhering to the AGREE II instrument and the Grading of Recommendations Assessment Development and Evaluation system are required to draft high-quality and reliable TDM guidelines. (C) 2019 Published by Elsevier Inc.

基金:
语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 2 区 医学
小类 | 2 区 卫生保健与服务 2 区 公共卫生、环境卫生与职业卫生
最新[2025]版:
大类 | 2 区 医学
小类 | 1 区 公共卫生、环境卫生与职业卫生 2 区 卫生保健与服务
JCR分区:
出版当年[2018]版:
Q1 HEALTH CARE SCIENCES & SERVICES Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
最新[2023]版:
Q1 HEALTH CARE SCIENCES & SERVICES Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2018版] 出版当年五年平均[2014-2018] 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者单位: [1]Department of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu, China [2]Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu, China [3]Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education (Sichuan University), Chengdu, China [4]West China School of Pharmacy, Sichuan University, Chengdu, China
通讯作者:
通讯机构: [1]Department of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu, China [2]Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu, China [3]Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education (Sichuan University), Chengdu, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:816 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)